Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
The University of Connecticut has added the Anatomage Medical table to its array of teaching tools used in its medical and dental schools. This interactive visualization system allows…
The PanAgora Summit helps address the concerns of various stakeholders throughout the medical professions and healthcare industries. These stakeholders are comprised of patients, physicians or primary care providers,…
Yelena Havryliuk, MD, FACOG Uterine fibroids are benign tumors that form on the muscle walls of the uterus. These fibroids are estimated to occur in 50-70% of females…
Martha Murray, MD explains how a new development in anterior cruciate ligament (ACL) injury treatment can help athletes recover faster and with better results than traditional methods. The…
For the past few decades, alpha-1 antitrypsin deficiency (AATD) treatment has been mostly limited to enzyme therapy. While this type of therapy is able to treat symptoms of…
For the past few decades, clinical trials related to alpha-1 antitrypsin deficiency (AATD), have focused on getting more replacement therapy on the market. New areas of AATD research focus…
Shiv Gaglani and Ryan Haynes, Co-Founders of Osmosis The Osmosis platform utilizes both cognitive techniques and thoughtful user experience design in its forward-thinking application for medical students. The goal…
Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults…
New advancements in the field of alpha-1 antitrypsin research hold promise for the treatment and possible reversal of liver disease. Recent advances in the safety and viability of…
Patients diagnosed with Acute Lymphoblastic Leukemia, the most common form of childhood cancer, are typically given Vincristine, a very powerful chemotherapy drug with a high toxicity called neuropathy…
